Skip to main content
. 2023 Dec 11;27:130. doi: 10.1186/s40824-023-00468-6

Table 4.

Cell preconditioning with non-inflammation related factors for EV engineering

No. Target cell Treatment material Concentration Ref.
1 RAW 264.7 Gemfibrozil 100 μg/ml [77]
2 RAW 264.7 Silibinin 50 μg/ml [78]
3 RAW 264.7 Edaravone 87.5 μg/ml [79]
4 SMC Cystatin C 1.95 μg/ml [80]
5 Dendritic cell Hemin 4.89 μg/ml [81]
6 Primary microglia and neurons Resveratrol 9.13 μg/ml [17]
7 BMSC TGFβ3 50 ng/ml [15]
8 BMSC Erythropoietin (EPO) 0.84 μg/ml [82]
9 BMSC tauroursodeoxycholic acid (TUDCA) 1.3 mg/ml [95]
10 BMSC Dimethyloxaloylglycine (DMOG) 0.17 mg/ml [96]
11 UCMSC Tanshinone IIA 2.94 μg/ml [85]
12 UCMSC Melatonin 4.65 μg/ml [16]
13 ADMSC Melatonin 4.65 μg/ml [87]
14 ADMSC Melatonin 2.32 ng/ml [90]
15 ADMSC Selenium 5 ng/ml [91]
16 ADMSC Curcumin 3.68 μg/ml [18]
17 ADMSC Ac4ManNAz 8.61 μg/ml [92]